SERIAL TISSUE POLYPEPTIDE SPECIFIC ANTIGEN DETERMINATIONS IN THE FOLLOWUP OF HORMONE TREATED CARCINOMA OF THE PROSTATE
β Scribed by Kramer, G.; Steiner, G.E.; Madersbacher, S.; Stulnig, T.; Lang, T.; Marberger, M.
- Book ID
- 122007521
- Publisher
- Lippincott Williams and Wilkins
- Year
- 1997
- Tongue
- English
- Weight
- 693 KB
- Volume
- 158
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Tissue polypeptide specific antigen (tps) recently was introduced as an indicator of cell proliferation in various tumors. the authors investigated the value of serum tps as a complement to alpha-fetoprotein (afp) in the detection of hepatocellular carcinoma (hcc) in chinese patients
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr